-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Avid Bioservices, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q2 2021 to Q2 2024.
- Avid Bioservices, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending July 31, 2024 was $0.000.
- Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $114M, a 8452% increase from 2022.
- Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $1.33M.
- Avid Bioservices, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$115M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)